Integration of AI in Medical Communications: A Roadmap
AI in medical communications: Why it matters now Artificial intelligence (AI) is rapidly reshaping medical communications (MedComms), driven by the necessity for personalization, efficiency, and speed in content delivery. As pharmaceutical companies face mounting competition, the demand for innovative communication strategies to communicate complex data and information, as early as the critical pre-launch phase, is…...
Read MoreTop Stories
The Nelson Memo: Igniting a Global Open Data
The landscape of scientific research is undergoing a seismic...
Rare Diseases – An Evolving Medical
A disease is considered rare when it affects fewer than 1 in...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
“Voice of Patient” in Publications: Trends and Perspectives
This page contains a poster presented at the 21st Annual Meeting of ISMPP (International Society for Medical Publication...
MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
Leveraging Social Media to Transform Medical Affairs
This whitepaper explores the role of social media in enhancing Medical Affairs functions. As digital...
Readability of Published vs. Artificial Intelligence (AI)-Generated Plain-Language Summaries (PLS)
PLS play an important role in increasing the accessibility of medical publications to a wide...
Use of Audiovisual Data Dissemination Formats (ADDFs) by Medical Journals: Then and Now
GPP 2022 guidelines endorse the use of alternative data dissemination formats, including ADDFs, to enhance...